Samantha K. McCarty, Ph.D.
Affiliations: | 2013 | Biomedical Sciences | Ohio State University, Columbus, Columbus, OH |
Area:
Medicine and Surgery, Molecular Biology, Oncology, Biomedical EngineeringGoogle:
"Samantha McCarty"Parents
Sign in to add mentor| Matthew Ringel | grad student | 2013 | Ohio State | |
| (A novel BRAF signaling cascade through p-21 activated kinases regulates thyroid cancer cell motility.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Shirley LA, McCarty S, Yang MC, et al. (2015) Integrin-linked kinase affects signaling pathways and migration in thyroid cancer cells and is a potential therapeutic target. Surgery |
| McCarty SK, Saji M, Zhang X, et al. (2014) BRAF activates and physically interacts with PAK to regulate cell motility. Endocrine-Related Cancer. 21: 865-77 |
| Ma Y, McCarty SK, Kapuriya NP, et al. (2013) Development of p21 activated kinase-targeted multikinase inhibitors that inhibit thyroid cancer cell migration. The Journal of Clinical Endocrinology and Metabolism. 98: E1314-22 |
| Koh YW, Shah MH, Agarwal K, et al. (2012) Sorafenib and Mek inhibition is synergistic in medullary thyroid carcinoma in vitro. Endocrine-Related Cancer. 19: 29-38 |
| Saji M, Narahara K, McCarty SK, et al. (2011) Akt1 deficiency delays tumor progression, vascular invasion, and distant metastasis in a murine model of thyroid cancer. Oncogene. 30: 4307-15 |
| McCarty SK, Saji M, Zhang X, et al. (2010) Group I p21-activated kinases regulate thyroid cancer cell migration and are overexpressed and activated in thyroid cancer invasion Endocrine-Related Cancer. 17: 989-999 |
| Espinosa AV, Shinohara M, Porchia LM, et al. (2009) Regulator of calcineurin 1 modulates cancer cell migration in vitro. Clinical & Experimental Metastasis. 26: 517-26 |